Dyne Therapeutics Overview
Dyne Therapeutics Target Price
Where could DYN trade next? Consensus target price: $38.
Get informed when a big investor buys or sells
+ FollowShare Price
$26.34
Average Target Price
$38.00
44.3% upside
44.3% upside4 analysts in the last 4 months
High: $50 | Low: $24
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-17 | H.C. WainwrightAndrew Fein | $50 | 89.8% upside |  |
| 2026-07-31 | Morgan Stanley | $45 | 70.8% upside | |
| 2026-05-15 | Evercore ISI | $33 | 25.3% upside | |
| 2026-05-13 | Bernstein | $24 |  8.9% downside | |
| 2026-03-02 | Chardan CapitalKeay Nakae | $38 | 44.3% upside | |
| 2026-03-02 | Morgan StanleyMichael E Ulz | $47 | 78.4% upside | |
| 2025-12-15 | Evercore ISIGavin Clark-Gartner | $36 | 36.7% upside | |
| 2025-12-11 | Stifel Nicolaus | $39 | 48.1% upside | |
| 2025-12-10 | Oppenheimer | $40 | 51.9% upside | |
| 2025-12-09 | Tudor PickeringWilliam Pickering | $23 | 12.7% downside | |
| 2025-12-09 | Bernstein | $23 | 12.7% downside | |
| 2025-12-08 | Morgan StanleyMichael E Ulz | $50 | 89.8% upside | |
| 2025-12-08 | Robert W. BairdBrian Skorney | $30 | 13.9% upside | |
| 2025-12-08 | H.C. WainwrightAndrew Fein | $60 | 127.8% upside | |
| 2025-12-08 | Raymond JamesMichael Freeman | $40 | 51.9% upside | |
| 2025-11-25 | Bernstein | $21 | 20.3% downside | |
| 2025-11-06 | Evercore ISIGavin Clark-Gartner | $38 | 44.3% upside | |
| 2025-10-10 | Oppenheimer | $13 | 50.6% downside | |
| 2025-08-25 | Raymond JamesStrong Buy | $35 | 32.9% upside | |
| 2025-06-02 | OppenheimerAndreas Argyrides | $34 | 29.1% upside | |
| 2025-02-28 | UBS | $48 | 82.2% upside | |
| 2025-02-28 | H.C. Wainwright | $46 | 74.6% upside | |
| 2024-08-14 | Morgan StanleyMichael Ulz | $52 | 97.4% upside | |
| 2024-08-13 | Piper SandlerEdward Tenthoff | $53 | 101.2% upside | |
| 2024-06-24 | JefferiesEun Yang | $42 | 59.5% upside | |
| 2024-06-17 | OppenheimerFrancois Brisebois | $55 | 108.8% upside | |
| 2024-05-21 | Chardan CapitalKeay Nakae | $42 | 59.5% upside | |
| 2024-05-20 | H.C. WainwrightAndrew Fein | $48 | 82.2% upside | |
| 2024-05-20 | Stifel NicolausPaul Matteis | $41 | 55.7% upside | |
| 2024-04-30 | Morgan StanleyMichael Ulz | $40 | 51.9% upside | |
| 2022-11-29 | J.P. Morgan | $18 | 31.7% downside | |
| 2022-09-06 | Piper SandlerEdward Tenthoff | $23 | 12.7% downside | |
| 2022-07-12 | Piper SandlerEdward Tenthoff | $17 | 35.5% downside | |